Literature DB >> 23233678

Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.

Emi Adachi1, Hiroyuki Nakajima, Chiharu Mizuguchi, Padmaja Dhanasekaran, Hiroyuki Kawashima, Kohjiro Nagao, Kenichi Akaji, Sissel Lund-Katz, Michael C Phillips, Hiroyuki Saito.   

Abstract

A number of naturally occurring mutations of apolipoprotein (apo) A-I, the major protein of HDL, are known to be associated with hereditary amyloidosis and atherosclerosis. Here, we examined the effects of the G26R point mutation in apoA-I (apoA-I(Iowa)) on the structure, stability, and aggregation propensity to form amyloid fibril of full-length apoA-I and the N-terminal fragment of apoA-I. Circular dichroism and fluorescence measurements demonstrated that the G26R mutation destabilizes the N-terminal helix bundle domain of full-length protein, leading to increased hydrophobic surface exposure, whereas it has no effect on the initial structure of the N-terminal 1-83 fragment, which is predominantly a random coil structure. Upon incubation for extended periods at neutral pH, the N-terminal 1-83 variants undergo a conformational change to β-sheet-rich structure with a great increase in thioflavin T fluorescence, whereas no structural change is observed in full-length proteins. Comparison of fibril-forming propensity among substituted mutants at Gly-26 position of 1-83 fragments demonstrated that the G26R mutation enhances the nucleation step of fibril formation, whereas G26K and G26E mutations have small or inhibiting effects on the formation of fibrils. These fibrils of the 1-83 variants have long and straight morphology as revealed by atomic force microscopy and exhibited significant toxicity with HEK293 cells. Our results indicate dual critical roles of the arginine residue at position 26 in apoA-I(Iowa): destabilization of the N-terminal helix bundle structure in full-length protein and enhancement of amyloid fibril formation by the N-terminal 1-83 fragment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23233678      PMCID: PMC3554949          DOI: 10.1074/jbc.M112.428052

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  A generic crystallization-like model that describes the kinetics of amyloid fibril formation.

Authors:  Rosa Crespo; Fernando A Rocha; Ana M Damas; Pedro M Martins
Journal:  J Biol Chem       Date:  2012-07-05       Impact factor: 5.157

Review 2.  Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity.

Authors:  Marcus Fändrich
Journal:  J Mol Biol       Date:  2012-01-12       Impact factor: 5.469

3.  Structural organization of the N-terminal domain of apolipoprotein A-I: studies of tryptophan mutants.

Authors:  W S Davidson; K Arnvig-McGuire; A Kennedy; J Kosman; T L Hazlett; A Jonas
Journal:  Biochemistry       Date:  1999-10-26       Impact factor: 3.162

4.  Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.

Authors:  Yuan Qi Wong; Katrina J Binger; Geoffrey J Howlett; Michael D W Griffin
Journal:  FEBS Lett       Date:  2012-05-15       Impact factor: 4.124

5.  Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization.

Authors:  Xiaohu Mei; David Atkinson
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

6.  Apolipoprotein E;-low density lipoprotein receptor interaction. Influences of basic residue and amphipathic alpha-helix organization in the ligand.

Authors:  M Zaiou; K S Arnold; Y M Newhouse; T L Innerarity; K H Weisgraber; M L Segall; M C Phillips; S Lund-Katz
Journal:  J Lipid Res       Date:  2000-07       Impact factor: 5.922

Review 7.  The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.

Authors:  Olga Gursky; Xiaohu Mei; David Atkinson
Journal:  Biochemistry       Date:  2011-12-29       Impact factor: 3.162

8.  Effects of the Iowa and Milano mutations on apolipoprotein A-I structure and dynamics determined by hydrogen exchange and mass spectrometry.

Authors:  Palaniappan Sevugan Chetty; Maki Ohshiro; Hiroyuki Saito; Padmaja Dhanasekaran; Sissel Lund-Katz; Leland Mayne; Walter Englander; Michael C Phillips
Journal:  Biochemistry       Date:  2012-10-24       Impact factor: 3.162

9.  A highly amyloidogenic region of hen lysozyme.

Authors:  Erica Frare; Patrizia Polverino De Laureto; Jesús Zurdo; Christopher M Dobson; Angelo Fontana
Journal:  J Mol Biol       Date:  2004-07-23       Impact factor: 5.469

10.  Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity.

Authors:  Nahuel A Ramella; Guillermo R Schinella; Sergio T Ferreira; Eduardo D Prieto; María E Vela; José Luis Ríos; M Alejandra Tricerri; Omar J Rimoldi
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more
  14 in total

1.  Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.

Authors:  Chiharu Mizuguchi; Fuka Ogata; Shiho Mikawa; Kohei Tsuji; Teruhiko Baba; Akira Shigenaga; Toshinori Shimanouchi; Keiichiro Okuhira; Akira Otaka; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

2.  Cellular interaction and cytotoxicity of the iowa mutation of apolipoprotein A-I (ApoA-IIowa) amyloid mediated by sulfate moieties of heparan sulfate.

Authors:  Kaori Kuwabara; Kazuchika Nishitsuji; Kenji Uchimura; Shang-Cheng Hung; Makoto Mizuguchi; Hiroyuki Nakajima; Shiho Mikawa; Norihiro Kobayashi; Hiroyuki Saito; Naomi Sakashita
Journal:  J Biol Chem       Date:  2015-08-19       Impact factor: 5.157

Review 3.  Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights.

Authors:  Madhurima Das; Olga Gursky
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

4.  Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.

Authors:  Chiharu Mizuguchi; Miho Nakagawa; Norihiro Namba; Misae Sakai; Naoko Kurimitsu; Ayane Suzuki; Kaho Fujita; Sayaka Horiuchi; Teruhiko Baba; Takashi Ohgita; Kazuchika Nishitsuji; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

5.  Membrane effects of N-terminal fragment of apolipoprotein A-I: a fluorescent probe study.

Authors:  Valeriya Trusova; Galyna Gorbenko; Mykhailo Girych; Emi Adachi; Chiharu Mizuguchi; Rohit Sood; Paavo Kinnunen; Hiroyuki Saito
Journal:  J Fluoresc       Date:  2015-01-18       Impact factor: 2.217

6.  Lipid Bilayer Interactions of Amyloidogenic N-Terminal Fragment of Apolipoprotein A-I Probed by Förster Resonance Energy Transfer and Molecular Dynamics Simulations.

Authors:  Galyna P Gorbenko; Valeriya Trusova; Chiharu Mizuguchi; Hiroyuki Saito
Journal:  J Fluoresc       Date:  2018-07-15       Impact factor: 2.217

7.  Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.

Authors:  Madhurima Das; Xiaohu Mei; Shobini Jayaraman; David Atkinson; Olga Gursky
Journal:  FEBS J       Date:  2014-04-28       Impact factor: 5.542

8.  Effect of curcumin on amyloid-like aggregates generated from methionine-oxidized apolipoprotein A-I.

Authors:  Aparna Krishnamoorthy; Narjes Tavoosi; Gary K L Chan; Jianfang Liu; Gang Ren; Giorgio Cavigiolio; Robert O Ryan
Journal:  FEBS Open Bio       Date:  2018-01-10       Impact factor: 2.693

9.  Amyloid triangles, squares, and loops of apolipoprotein C-III.

Authors:  Michel de Messieres; Rick K Huang; Yi He; Jennifer C Lee
Journal:  Biochemistry       Date:  2014-05-13       Impact factor: 3.162

10.  Iowa Mutant Apolipoprotein A-I (ApoA-IIowa) Fibrils Target Lysosomes.

Authors:  Hirokazu Kameyama; Hiroyuki Nakajima; Kazuchika Nishitsuji; Shiho Mikawa; Kenji Uchimura; Norihiro Kobayashi; Keiichiro Okuhira; Hiroyuki Saito; Naomi Sakashita
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.